A New Approach page top left image

Shared resources

Biomedical researchers require a broad spectrum of techniques and instruments — such as statistical programs to analyze research results, microscopes to peer into neurons, and robots to increase research efficiency. The Harvard NeuroDiscovery Center provides its 700+ members access to such sophisticated resources throughout the Harvard community. Each shared resource goes well beyond simple access to equipment. We provide users with invaluable technical and intellectual support, guiding hundreds of Harvard NeuroDiscovery Center members every year to help solve the many puzzles of neurodegenerative diseases.  

Shared resources at the Harvard NeuroDiscovery Center are summarized below, with details at left. 

Advanced technologies

The Harvard NeuroDiscovery Center provides access to MRIs and a full array of powerful microscopes — all key to neurodegenerative research. Similarly, through our Advanced Tissue Research Center, members have ready access to valuable samples (including brain tissue, cells, DNA, etc.) required for neurodegenerative disease research. In all instances, senior staff offer full training and support tailored to the needs of novices and experts alike.   

Pilot Study Grants

Typically involving less than 10 subjects, pilot studies permit investigators to test the feasibility of a full-scale study, refine research instruments, and generate preliminary data. A successful pilot study will help investigators make a strong case for the much more substantial funding necessary to conduct full-scale clinical trials. Recognizing the importance of pilot studies to advance potential new treatments, the Harvard NeuroDiscovery Center selects and supports many pilot trials. The typical cost for one early-stage pilot trial is $10,000 to $30,000.

Training and education

Since 2001 the Harvard NeuroDiscovery Center has provided over $10 million in fellowships and training awards to talented individuals with real potential for advancing biomedical research. Our goal is to ensure a pipeline of talented scientists committed to curing neurodegenerative disease. We also regularly sponsor seminars, symposia and other important meetings with leading researchers from academia and industry. These meetings generate new research direction, give rise to new collaborations and allow investigators to share their knowledge and insight with other researchers working on these diseases.